Impact of Serial B-Type Natriuretic Peptide Changes for Predicting Outcome in Asymptomatic Patients With Aortic Stenosis

Canadian Journal of Cardiology

Volumn 32, Issue 2, 2016, Pages 183-189

  Henri, Christine ^a,b   Dulgheru, Raluca ^a   Magne, Julien ^a   Caballero, Luis ^a   Laaraibi, Saloua ^a   Davin, Laurent ^a   Kou, Seisyou ^a   Voilliot, Damien ^a   Nchimi, Alain ^a   Oury, Cécile ^c   Pierard, Luc A ^a   Lancellotti, Patrizio ^a,d  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d Research Ettore Sansavini Health Science Foundation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

AGE; AGED; AORTA STENOSIS; ARTICLE; DYSLIPIDEMIA; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; SURVIVAL RATE; SURVIVAL TIME; TRANSTHORACIC ECHOCARDIOGRAPHY; AORTIC VALVE STENOSIS; ASYMPTOMATIC DISEASE; BLOOD; DISEASE COURSE; DISEASE FREE SURVIVAL; DOPPLER ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

AGED; AORTIC VALVE STENOSIS; ASYMPTOMATIC DISEASES; BIOMARKERS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84959161092     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2015.06.007     Document Type: Article

References (24)

1. Iung B., Baron G., Butchart E.G., et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003, 24:1231-1243.
2. Vahanian A., Alfieri O., Andreotti F., et al. Guidelines on the management of valvular heart disease (version 2012): Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012, 33:2451-2496.
3. Nishimura R.A., Otto C.M., Bonow R.O., et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014, 129:e521-643.
4. Amato M.C., Moffa P.J., Werner K.E., Ramires J.A. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart 2001, 86:381-386.
5. Das P., Rimington H., Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J 2005, 26:1309-1313.
6. Carabello B.A. Should severe aortic stenosis be operated on before symptom onset? Aortic valve replacement should be operated on before symptom onset. Circulation 2012, 126:112-117.
7. Shah P.K. Should severe aortic stenosis be operated on before symptom onset? Severe aortic stenosis should not be operated on before symptom onset. Circulation 2012, 126:118-125.
8. Burgess M.I., Jenkins C., Sharman J.E., Marwick T.H. Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise. J Am Coll Cardiol 2006, 47:1891-1900.
9. Bergler-Klein J., Klaar U., Heger M., et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004, 109:2302-2308.
10. Lancellotti P., Moonen M., Magne J., et al. Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis. Am J Cardiol 2010, 105:383-388.
11. Lim P., Monin J.L., Monchi M., et al. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J 2004, 25:2048-2053.
12. Klaar U., Gabriel H., Bergler-Klein J., et al. Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation. Eur J Heart Fail 2011, 13:163-169.
13. Pizarro R., Bazzino O.O., Oberti P.F., et al. Prospective validation of the prognostic usefulness of B-type natriuretic peptide in asymptomatic patients with chronic severe aortic regurgitation. J Am Coll Cardiol 2011, 58:1705-1714.
14. Henri C., Magne J., Dulgheru R., et al. Usefulness of serial B-type natriuretic peptide assessment in asymptomatic aortic stenosis. Am J Cardiol 2014, 114:441-448.
15. Lancellotti P., Donal E., Magne J., et al. Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay. Heart 2010, 96:1364-1371.
16. Baumgartner H., Hung J., Bermejo J., et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009, 10:1-25.
17. Gerber I.L., Legget M.E., West T.M., Richards A.M., Stewart R.A. Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration. Am J Cardiol 2005, 95:898-901.
18. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002, 40:976-982.
19. Vanderheyden M., Goethals M., Verstreken S., et al. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol 2004, 44:2349-2354.
20. Qi W., Mathisen P., Kjekshus J., et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J 2001, 142:725-732.
21. Dalsgaard M., Egstrup K., Wachtell K., et al. Left atrial volume in patients with asymptomatic aortic valve stenosis (the Simvastatin and Ezetimibe in Aortic Stenosis study). Am J Cardiol 2008, 101:1030-1034.
22. Clavel M.A., Malouf J., Michelena H.I., et al. B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. J Am Coll Cardiol 2014, 63:2016-2025.
23. Bergler-Klein J., Gyöngyösi M., Maurer G. The role of biomarkers in valvular heart disease: focus on natriuretic peptides. Can J Cardiol 2014, 30:1027-1034.
24. Rosenhek R., Binder T., Porenta G., et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000, 343:611-617.